CROI 2026: Phase III data show once-daily Eslatravir/Ravin matches BFTAF in treatment‑naive HIV, achieving high viral suppression at 48 weeks.
Jürgen Rockstroh, MD
Advertisement
Jürgen Rockstroh, MD, is Professor of Medicine and Head of the HIV Outpatient Clinic at the University of Bonn in Germany.
Articles by Jürgen Rockstroh, MD
HIV specialist Jürgen Rockstroh, MD, discusses the importance of PrEP being more accessible through primary care physicians.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Patient Care Online
1
AI Drafts for Patient Portal Replies May Increase Primary Care Clinician Editing Burden
2
Subcutaneous Lecanemab Shows Comparable Exposure in Early Alzheimer Disease
3
WHO Warns Global Cancer Cases Could Reach 35 Million Annually by 2050
4